Smart Search
Latest Studies
Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial
Asthma is a chronic inflammatory disease of the airways mediated, at least in part, by leukotrienes and other lipid mediators. Experimental studies have shown that lipid extract of New Zealand green-lipped mussel, Perna canaliculus, is effective in inhibiting 59-lipoxygenase and cyclo-oxygenase pathways responsible for production of eicosanoids, including leukotrienes and prostaglandins.
The Asthma Journal of New Zealand Treatment of Asthma Emelyanov & Barnes
Asthma is a chronic inflammatory disease of the airways mediated at least in part by leukotrienes and other lipid mediators. Experimental studies have shown that lipid extract of New Zealand Green-lipped mussel, Perna canaliculus, is effective in inhibiting 5'- Lipoxygenase and cyclo-oxygenase pathways responsible for production of eicosanoids, including leukotrienes and prostaglandins.